All
FDA Convenes Advisory Committee for the Second Time for ALS Therapy
July 5th 2022The Peripheral and Central Nervous System Drugs Advisory Committee will meet for a second time in September 2022 to discuss new analysis of the data for AMX0035 for the treatment of patients with amyotrophic lateral sclerosis.